 |
NYON, Switzerland, Oct. 12, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the FDA for its "Breakthrough Program". SELUTION...
At a Glance Singapore offers financial structure and tax transparency. Dubai enables trade agility and access to GCC ma...
Leaders from both sides voiced optimism about the plan The debut product reflects growing cross-border ambitions in prem...
When people ask me what drives success, I always smile before answering. Because after two decades of leading teams, launch...
As the current Artist in Residence at Hub Australia, Freya Alexander is bringing colour and creativi...
The defence treaty between Australia and Indonesia faces its most difficult test because of econ...
When it comes to property transactions, not every situation requires a full, detailed valuation. I...
What moved, why it moved and what to watch going forward. 📉 Market overview The benchmark S&am...
The National Disability Insurance Scheme (NDIS) was set up in 2013[1] to help Australians with...
As Australians rethink what fitness actually means going into the new year, a clear shift is emergin...
There’s an undeniable magic in contrast — the way gold catches the light while silver cools it down...
When local singer Alyssa Delpopolo was crowned winner of The Voice last week, the cheers were louder...
Walk into any big Australian supermarket and the first thing that hits you isn’t the smell of fr...